Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management-Reference-Cited by-同舟云学术

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management

Published:2023-02-08 Issue:1 Volume:32 Page:25-45
ISSN:2508-6235
Container-title:Journal of Obesity & Metabolic Syndrome
language:en
Short-container-title:Journal of Obesity & Metabolic Syndrome

Author:

Sinha Rachel¹,Papamargaritis Dimitris¹²^ORCID,Sargeant Jack A.¹²,Davies Melanie J.¹²

Affiliation:

1. Diabetes Research Centre, University of Leicester College of Life Sciences, Leicester, UK

2. National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre, University Hospital of Leicester NHS Trust and the University of Leicester, Leicester, UK

Funder

National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre

Publisher

Korean Society for the Study of Obesity

Subject

Endocrinology, Diabetes and Metabolism

Link

http://pdf.medrang.co.kr/KSSO2/2023/032/jomes-32-1-25.pdf

Reference89 articles.

1. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

2. The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials

3. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way

4. Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery

5. Obesity: The Gateway to Ill Health - an EASO Position Statement on a Rising Public Health, Clinical and Scientific Challenge in Europe

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survodutide, a new horizon in the treatment of obesity and Type 2 diabetes mellitus: A narrative review;Yemen Journal of Medicine;2024-09-15

2. Tirzepatide a novel anti diabetic molecule unfold dual action;Discover Public Health;2024-09-05

3. GLP-1R mediates idebenone-reduced blood glucose in mice;Biomedicine & Pharmacotherapy;2024-09

4. Tirzepatide: unveiling a new dawn in dual-targeted diabetes and obesity management;Expert Review of Endocrinology & Metabolism;2024-08-28

5. Bridging the Gap: A Literature Review of Advancements in Obesity and Diabetes Mellitus Management;Applied Sciences;2024-07-27